BioSpace News Archive

WatchPAT™ to effectively maintain current reimbursement levels despite broader reduction in conversion rates

Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced updates on the clinical development of the company’s novel Bcl-2 inhibitor APG-2575, further demonstrating the drug candidate’s therapeutic potential.

Biogen and Eisai, Co., Ltd. announced that Biogen has submitted a Japanese New Drug Application to the Ministry of Health, Labor and Welfare for aducanumab, an investigational therapy for Alzheimer’s disease.

On December 9, 2020, Kintor Pharmaceutical Limited is pleased to announce that the Group has collected positive data in phase II clinical trials of combination therapy of ALK-1 antibody and PD-1 antibody for the second line therapy of advanced hepatocellular carcinoma in Taiwan.

Rocket Pharmaceuticals, Inc., a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, announces the pricing of an upsized underwritten public offering of 4,642,858 shares of its common stock at a public offering price of $56.00 per share.

Today, Elektra Labs and Scripps Research Translational Institute (SRTI) announced that the Digital Health Library (DHL), a crowd-sourced collection of technologies compiled by SRTI to address health and research needs, will now be integrated with Elektra’s Atlas,

With the assets, BioLab will be able to accelerate the availability of the patented MyOwn Skin™ globally and make advanced wound care more accessible PHOENIX--( BUSINESS WIRE )-- BioLab Sciences , an emerging regenerative biotechnology company, announced today it has acquired the patents and intellectual property for MyOwn Skin™, a revolutionary regenerative therapy that is transforming the wound care industry, from Bogota, Colombia-based Keraderm. T

Company focused on broadening access to innovative solutions for people with type 1 and type 2 diabetes and designing high-touch customer care experiences

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW) , a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today issued a public statement encouraging those battling alcohol and other substance use disorders to refrain from driving under the influence, especially during the holiday season.

ams (SIX: AMS), a leading worldwide supplier of high performance sensor solutions, and Senova, a manufacturer of in-vitro diagnostic medical devices based in Germany, announce yesterday that they have successfully opened a production line for lateral flow tests which will be used to detect antibodies from the Covid-19 (SARS-CoV-2) virus